• Depression & TMS
• Transcranial Magnetic Stimulation
• Neurostar TMS Therapy
• TMS Testimonials

• 
• 
• 
• 
• 

Neurostar® Safety

Clinical trials have demonstrated the safety of NeuroStar TMS Therapy® in treating patients who have had an inadequate response to prior antidepressant medications.

Treatment with NeuroStar TMS Therapy caused very few side effects and was generally well tolerated by patients. The most common side effect reported during clinical trials was scalp discomfort—generally mild to moderate and occurring less frequently after the first week of treatment.

Fewer than 5% of patients discontinued treatment with NeuroStar TMS Therapy due to adverse events.

Over 10,000 active treatments were performed across all NeuroStar® clinical trials demonstrating its safety¹

• No systemic side effects
  • No weight gain
  • No sexual dysfunction
  • No sedation
  • No nausea
  • No dry mouth
• No adverse effects on concentration or memory
• No drug interactions
• NeuroStar TMS Therapy should not be used in patients with implanted metallic devices or non-removable metallic objects in or around the head. This does not include metallic fillings in teeth.
• NeuroStar TMS Therapy should not be used in patients with implants controlled by physiological signals. This includes pacemakers, implantable cardioverter defibrillators (ICDs), and vagus nerve stimulators (VNS).

Learn about a typical NeuroStar TMS Therapy treatment session.

References:

1. Janicak, P, et al. Transcranial Magnetic Stimulation (TMS) in the Treatment of Major Depression: A Comprehensive Summary of Safety Experience from Acute Exposure, Extended Exposure and During Reintroduction Treatment. Journal of Clinical Psychiatry, February 2008.

Contact Kenneth E Goolsby MD & Associates PC

Phone:
770-534-8832

Office hours:
8am-5pm M thru F

Address:
1990 Limestone Circle Ste 110
Gainesville, GA 30501

Get directions to
Kenneth E Goolsby MD & Associates PC >>

In the Media:

• 08/19/2024 TMS for OCD: Does It Work?
• 08/16/2024 Clinical Predictors of Response to Repetitive Transcranial Magnetic Stimulation for Depression
• 05/31/2024 Can A New FDA-Cleared Treatment Help Address Depression in Adolescents?
• 05/10/2024 When Antidepressants Fail, This Treatment May Offer Hope
• 04/18/2024 NeuroStar TMS and the Future of MDD Treatment for Adolescents